Clinical trial

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

NCT06390930

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-02-01

PhaseNA

Study timeline

Study start (actual)2025-02-01Date precision: day

Registry last updated2026-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Multiple Sclerosis, Relapsing-Remittingunresolved

Multiple Sclerosis, Secondary Progressiveunresolved

Interventions

Acute Intermittent HypoxiaOTHER

Sham Acute Intermittent HypoxiaOTHER

Sponsors & collaborators

Shirley Ryan AbilityLablead sponsor

National Multiple Sclerosis Societycollaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06390930 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.